Clinical trials: Leukemia, Myelogenous, Chronic
Chronic Myeloid Leukemia
Safety and Efficacy of Imatinib in Combination With High Dose Chemotherapy for Acute Phase Chronic Myelogenous Patients
The aim of this phase I/II trial is to determine the dose of daunorubicine to be associated with cytarabine and Imatinib for induction therapy in patients with chronic myelogenous leukemia in myeloid acute phase.
- Trial name
- NCT00219765
- Testing
- Imatinib mesylate 600 mg, Cytarabine, Daunorubicine
- Where
- France
- Volunteers
- 30 people
- Sponsor
- Poitiers University Hospital
Leukemia,Myeloid, Chronic, Leukemia,Myeloid,Philadelphia-Positive
Study Using Vaccination With Heat Shock Protein 70 (HSP70) for the Treatment of CML in Chronic Phase
Description: The trial is designed to determine the response of the immune system of patients with CML to a vaccine made from their own tumor.
- Trial name
- NCT00027144
- Testing
- Heat Shock Protein 70 HSP70
- Where
- United States
- Volunteers
- 10 people
- Sponsor
- University of Connecticut